British American Tobacco Share Discussion Threads

[minerve 2] 24/4/2020 14:20

Perhaps smoking limits the production or attachment to the ACE2 enzyme.

[p0pper] 24/4/2020 13:17

Possibly smokers lungs so tarred up that the virus can't get through

[eeza] 24/4/2020 13:05

Yes, it's interesting because with compromised lung capacity you would expect the reverse to be true.

[npp62] 24/4/2020 12:23

Yep. French hospitals have noticed how very few of those admitted with CV-19 are smokers.

[eeza] 22/4/2020 23:09

French researchers to test nicotine patches on coronavirus patients
Study – which stresses serious health risks of smoking – suggest substance in tobacco may lower risk of getting coronavirus.....more

[buywell2] 17/4/2020 04:01

IMO one would have to put this chart down as yet another that seems to indicate that
the market is set for another leg down.

Anyone else noticed this on other charts ?

2000p set for a retest ?

[richard xii] 15/4/2020 16:41

I assume the sanctions are not any authorized by the UN but those authorized by the US. If you would expect BAT to comply with US sanctions against Iran would you also expect it to comply say with sanctions authorized by Iran against the US? If this is the case BAT had to decide whether to comply, risk retribution or withdraw from its activities in the US if it did not wish to do business with such an entity.

[philanderer] 14/4/2020 23:43

MARKET REPORT: US criminal probe is a drag for British American Tobacco as it is suspected of breaches of sanctions


Shares in British American Tobacco began the week in the red following reports it is facing a criminal probe in the US over suspected breaches of sanctions.

The FTSE 100-listed cigarette giant is cooperating with the US Department of Justice and an intelligence agency that sits under the US Treasury department, the Office of Foreign Assets Control.

BAT had flagged in its annual report last month it was aware an investigation was under way.

It has declined to say whether the case is a criminal probe – but if it is, then it could be a serious and costly blow for the Lucky Strike and Dunhill maker.

The details are still scant, with neither BAT nor US authorities revealing which country or countries the inquiry is concentrating on.

But Jefferies analysts believe it could relate to an ongoing case in the UK, in which the Serious Fraud Office is examining 'suspicions of corruption' that followed allegations made in The Guardian newspaper about BAT paying bribes in Africa.

Jefferies adopted a wait-and-see approach to the investigation, saying: 'If we are right, and it does relate to the same accusations, the fact this has been ongoing in some form since 2017, with no apparent conclusion (that we are aware of) we would not worry too much about it for now.'

Investors were a little more cautious – with BAT falling 3.4 per cent, or 102p, to 2918.5p.

[simonc5] 14/4/2020 21:39

Was going to buy this share but think i will steer clear after these alleged breaches have been reported

[philanderer] 14/4/2020 13:43

Here's the story that peteriro flagged up..

British American Tobacco shares slipped 4.3%. The Times reported that the Lucky Strike cigarette maker is under investigation in the US over suspected sanctions breaches.

The Department of Justice and the Office of Foreign Assets Control, which is part of the US Department of the Treasury and enforces US trade sanctions, are investigating "suspicions of breach of sanctions", The Times said. It is not clear which territory the regulators are focusing on, the newspaper added.

Alliance News

[simba_] 14/4/2020 11:41

Sanctions?

[peteriro] 14/4/2020 10:02

Looks like something to do with USA sanctions. BATS are under investigation. Cannot believe it myself from a well respected trading company.

[basem1] 14/4/2020 09:42

Any reason for the fall today ?

[skinny] 02/4/2020 12:37

Post 3621 - I posted this yesterday on the IMB thread :-

"It would be in pretty poor taste if it were!

From their website" :-

.

[ohojim] 02/4/2020 12:32

Lol, they only got the 38% retrace. But then they are not working on the cure for Covid I guess.

[eeza] 02/4/2020 12:21

Can you stroke IMB, please.

[ohojim] 02/4/2020 12:08

Coming into some likely resistance area now, but what a great run. The only winner in my er..."capital growth" portfolio.

img url

[karateboy] 02/4/2020 10:39

It is real not a 1st April fool rumour. It is a very good news and if vaccine really works then BATS will be saving life!

[spoole5] 01/4/2020 20:29

Bats created this virus, BATS will solve it!

[muscletrade] 01/4/2020 18:20

Cigarette maker BAT claims coronavirus vaccine breakthrough
Testing a vaccine on tobacco plants paves the way towards millions of doses being produced a week
By
Oliver Gill
1 April 2020 • 4:26pm
Premium
The world’s second-biggest cigarette maker claims to have made a “significant breakthrough” in the race to find a vaccine for the coronavirus and would be ready to start mass production within three months.

British American Tobacco (BAT), the FTSE 100 company behind Lucky Strike and Dunhill, said it could be producing up to 3m million doses of a vaccine a week by June - far faster than rivals, which are expecting to take at least a year.

BAT intends to start trialling its vaccine in humans as soon as possible. It is running pre-clinical tests and holding urgent talks with US drug authorities to fast-track permissions.

The treatment is being developed by the company's health division Kentucky BioProcessing (KBP), which has previously come up with a drug to combat Ebola. It claims to have found an antibody that appears to fight Covid-19, and is manufacturing this using genetically modified tobacco plants.

City analysts called the announcement “somewhat surprising”. Shares rose 4pc.

More established medical firms have said the timeline for delivering a vaccine is far slower.

The company has opened talks with the Department for Health as well as US regulators. “BAT is now exploring partnerships with government agencies to bring its vaccine to clinical studies as soon as possible."


Owen Bennett of Jefferies said: "It helps to illustrate the scientific sophistication at big tobacco."

If the scheme is successful it will give BAT's reputation a massive boost, he added.

BAT's scientific research director David O’Reilly said: “Vaccine development is challenging and complex work, but we believe we have made a significant break-through with our tobacco plant technology platform and stand ready to work with governments and all stakeholders to help win the war against Covid-19.

“KBP has been exploring alternative uses of the tobacco plant for some time. One such alternative use is the development of plant-based vaccines. We are committed to contributing to the global effort to halt the spread of Covid-19 using this technology.”

BAT is not alone in turning its attention to developing a vaccine. Earlier this week US consumer goods giant Johnson & Johnson announced a $1bn (£810m) deal with Washington to ramp up testing.

[eeza] 01/4/2020 13:59

British American Tobacco (BAT) has become the latest firm to join the race to develop a vaccine against Covid-19.

The group said its US-based biotech business had been working on a potential antigen using genetically-engineered tobacco plants, which it believes could offer up to 3m doses a week from June.

BAT said its US-based biotech business had been working on a potential vaccine for Covid-19.

On Wednesday, BAT said the vaccine was in pre-clinical testing at Kentucky BioProcessing (KBP). Dr David O’Reilly, director of scientific research at BAT, said:

Vaccine development is challenging and complex work, but we believe we have made a significant breakthrough with our tobacco plant technology platform and stand ready to work with governments and all stakeholders to help win the war against Covid-19.

“We fully align with the United Nations plea, for a whole-of-society approach to combat global problems.”

The group is in talks with the US Food and Drug Administration and the UK’s Department of Health and Social Care in the hope of partnering with government agencies to bring the vaccine to clinical studies.

BAT, which makes brands including Lucky Strike, Camel, and Vype e-cigarettes, has secured a £2.4bn debt package from banks and reported no material downturn in trading, despite concerns about the impact of smoking on those who contract the virus."


Guardian live news